We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$234M
AUM Growth
-$5.63M
Cap. Flow
-$22.7M
Cap. Flow %
-9.71%
Top 10 Hldgs %
77.03%
Holding
114
New
24
Increased
15
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.24M
2
ATCO
Atlas Corp.
ATCO
+$963K
3
XRN.PRA
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
+$871K
4
KMB icon
Kimberly-Clark
KMB
+$733K
5
RXDX
Ignyta, Inc.
RXDX
+$698K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$25.4M
2
AGN
Allergan plc
AGN
+$2.3M
3
PFE icon
Pfizer
PFE
+$1.93M
4
ABBV icon
AbbVie
ABBV
+$1.35M
5
DD
Du Pont De Nemours E I
DD
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 70.52%
2 Financials 8.46%
3 Technology 4.11%
4 Real Estate 3.89%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UAL icon
51
United Airlines
UAL
$35.9B
$609K 0.26%
+10,000
New +$666K
KO icon
52
Coca-Cola
KO
$386B
$603K 0.26%
13,400
+7,600
+131% +$346K
EW icon
53
Edwards Lifesciences
EW
$52B
$535K 0.23%
14,673
– –
CDOR
54
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$523K 0.22%
50,000
– –
VIVE
55
DELISTED
VIVEVE MED INC
VIVE
$502K 0.21%
96
+42
+78% +$259K
ARNA
56
DELISTED
Arena Pharmaceuticals Inc
ARNA
$501K 0.21%
+19,642
New +$451K
CHEKW
57
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$495K 0.21%
66,059
– –
SHPG
58
DELISTED
Shire pic
SHPG
$460K 0.2%
+3,003
New +$471K
SGYP
59
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$459K 0.2%
158,400
– –
CHRS icon
60
Coherus Oncology
CHRS
$218M
$458K 0.2%
34,320
+12,000
+54% +$159K
WPC icon
61
W.P. Carey
WPC
$16.1B
$404K 0.17%
+6,126
New +$407K
PCSB
62
DELISTED
PCSB Financial Corporation
PCSB
$377K 0.16%
20,000
– –
AXGN icon
63
Axogen
AXGN
$2.77B
$366K 0.16%
18,898
– –
CAG icon
64
Conagra Brands
CAG
$7.72B
$337K 0.14%
+10,000
New +$340K
ANCB
65
DELISTED
Anchor Bancorp
ANCB
$303K 0.13%
12,250
– –
MBAI
66
Check-Cap
MBAI
$9.05M
$298K 0.13%
+97
New +$295K
CORV
67
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$286K 0.12%
134,478
-100
-0.1% -$340
TTE icon
68
TotalEnergies
TTE
$191B
$281K 0.12%
5,260
– –
ALIM
69
DELISTED
Alimera Sciences
ALIM
$269K 0.12%
+13,267
New +$284K
REED
70
DELISTED
Reeds, Inc. Common Stock
REED
$259K 0.11%
2,352
– –
ZGNX
71
DELISTED
Zogenix, Inc.
ZGNX
$249K 0.11%
+7,100
New +$96.4K
RLOG
72
DELISTED
Rand Logistics, Inc.
RLOG
$210K 0.09%
664,435
– –
GIS icon
73
General Mills
GIS
$22.2B
$202K 0.09%
+5,000
New +$274K
TPST icon
74
Tempest Therapeutics
TPST
$17.5M
$196K 0.08%
47
+42
+840% +$180K
IRT icon
75
Independence Realty Trust
IRT
$3.84B
$170K 0.07%
16,700
-33,300
-67% -$337K
1 2
3
4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2017 Portfolio in Review

As of Q3 2017, David M. Knott held 114 positions worth $234M, down 2.4% from $240M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

David M. Knott withdrew a net $22.7M in Q3 2017, closing 6 positions and reducing 9 holdings. Its most notable exit was Allergan plc, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 73% a quarter earlier, followed by Financials and Technology.

Against the trend, David M. Knott opened a new position in Atlas Corp. worth $993K.

  • David M. Knott's largest Q3 2017 buy was Atlas Corp.: 140,000 shares worth $993K.
  • David M. Knott added most to DuPont de Nemours in Q3 2017, an estimated $1.24M increase.
  • David M. Knott's biggest Q3 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $25.4M.
  • David M. Knott fully exited Allergan plc in Q3 2017, selling an estimated $2.3M.
  • David M. Knott's ten largest holdings make up 77% of its $234M portfolio in Q3 2017.
  • David M. Knott opened 24 new positions and closed 6 in Q3 2017.
  • David M. Knott's portfolio value fell 2.4% quarter-over-quarter to $234M.

Based on David M. Knott's 13F filing for Q3 2017, filed 13 Nov 2017.